#EBW26 Previews: Keynote with Aneta Tyszkiewicz
We are excited to announce that the second keynote of #EBW26 will be delivered by Aneta Tyszkiewicz, Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA). The subject of the keynote will be ‘From scientific excellence to industrial leadership: Strengthening Europe’s attractiveness for research and innovation through the EU Biotech Act’.
Aneta Tyszkiewicz
Aneta is Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the R&D-based pharmaceutical industry in Europe. She leads EFPIA’s policy and advocacy on data, real-world evidence and emerging technologies, including biotechnologies.
Her work focuses on advancing the digital transformation of healthcare in Europe to enable the development of innovative, trusted solutions that deliver tangible benefits for patients.
Aneta previously held roles at the Council of European Dentists, the International Diabetes Federation and in consulting.
Keynote abstract
Europe stands at a pivotal moment in global biotechnology. While its scientific base remains strong, fragmentation, insufficient investment and regulatory complexity risk undermining its competitiveness.
The Biotech Act offers a unique opportunity to create a coherent, innovation-friendly ecosystem that enables research, development and manufacturing to scale in Europe. To deliver, it must combine effective incentives, a truly harmonised clinical trials system, regulatory simplification, strategic investment and a robust framework for data and AI.
With the right ambition, Europe can move beyond incremental change and position itself as a global leader in biotechnology, ensuring faster patient access and long-term economic growth.
Session details
- Date: Thursday 21 May
- Time: 11:15 – 12:15